Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

CTMX

CytomX Therapeutics Inc

May 14 • 04:00PM ET

3.78

-0.01 -0.26 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: XNCR ZYME STRO JANX NRIX

| Held by: VTI XBI VXF IBB VHT FDM FFSM LABU DFAS IDNA

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.36	Insider Own	21.63%	Shs Outstand	217.69M	Perf Week	-5.50%
Market Cap	822.91M	Forward P/E	-	EPS next Y	-0.51	Insider Trans	-0.40%	Shs Float	170.61M	Perf Month	-17.11%
Enterprise Value	479.06M	PEG	-	EPS next Q	-0.08	Inst Own	64.28%	Short Float	17.43%	Perf Quarter	-30.39%
Income	-62.14M	P/S	23.15	EPS this Y	-184.08%	Inst Trans	5.13%	Short Ratio	4.39	Perf Half Y	-7.80%
Sales	35.54M	P/B	2.57	EPS next Y	-19.42%	ROA	-25.83%	Short Interest	29.74M	Perf YTD	-11.27%
Book/sh	1.47	P/C	2.37	EPS next 5Y	-	ROE	-34.29%	52W High	8.21 -53.96%	Perf Year	58.82%
Cash/sh	1.59	P/FCF	-	EPS past 3/5Y	53.93% 27.00%	ROIC	-18.48%	52W Low	1.72 119.77%	Perf 3Y	112.36%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.75% -5.36%	Gross Margin	96.51%	Volatility	5.82% 6.04%	Perf 5Y	-53.68%
Dividend TTM	-	EV/Sales	13.48	EPS Y/Y TTM	-173.33%	Oper. Margin	-182.20%	ATR (14)	0.27	Perf 10Y	-62.20%
Dividend Ex-Date	-	Quick Ratio	10.38	Sales Y/Y TTM	-75.91%	Profit Margin	-174.84%	RSI (14)	33.67	Recom	1.11
Dividend Gr. 3/5Y	- -	Current Ratio	10.38	EPS Q/Q	-138.13%	SMA20	-10.50%	Beta	2.13	Target Price	13.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-79.85%	SMA50	-15.68%	Rel Volume	0.36	Prev Close	3.79
Employees	69	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	-3.35%	Avg Volume	6.78M	Price	3.78
IPO	Oct 08, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.42% 119.08%	Trades		Volume	2,454,662	Change	-0.26%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)